drugset / Trial / NCT02281591
Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine
RandomizedParallel-groupOpen-labelTreatment
Summary
Single centre, open-label, randomised study in four parallel groups of healthy volunteers
Timeline
- Start
- 2006-06
- Primary completion
- 2006-07
- Completion
- 2006-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eslicarbazepine acetate | Unknown | 450 mg | Oral |
| Comparator | Eslicarbazepine acetate | Unknown | 900 mg | Oral |
| Comparator | R-licarbazepine | Unknown | 450 mg | Oral |